CCL26 and posterior cortical atrophy: PCa patients with a high riskscore had higher levels of CXCL14, CCL24, and CCL26 expression, while patients with a high riskscore exhibited lower levels of CCL20 expression (Supplemental Figures 8A–D), which was consistent with the coefficients of the CRPGS.